ArticleJournal of the National Cancer Center2021

Durable clinical response to the multidisciplinary management of neurosurgery, radiation and chemoimmunotherapy in a patient with PD-L1/PD-L2/JAK2 (PDJ)-amplified, refractory triple-negative breast cancer.

Hongyuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.